NASDAQ · CLOV
Healthcare · Medical - Healthcare Plans
$4.23
Down-$0.02 (-0.47%)
Updated Aug 28, 2026, 9:51 AM
SID Score
5.3/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 21 trading sessions · Daily adjusted prices
CLOV closed at $4.23 after 21 trading sessions, down 2.53% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 27, 2026 | $4.32 | $4.3453 | $4.225 | $4.23 | 3.38M |
| Aug 26, 2026 | $4.10 | $4.3131 | $4.10 | $4.25 | 3.2M |
| Aug 25, 2026 | $4.16 | $4.19 | $4.035 | $4.13 | 2.71M |
| Aug 24, 2026 | $4.15 | $4.18 | $4.08 | $4.11 | 2.76M |
| Aug 21, 2026 | $4.14 | $4.18 | $4.085 | $4.15 | 2.72M |
| Aug 20, 2026 | $4.18 | $4.26 | $4.095 | $4.10 | 3.91M |
| Aug 19, 2026 | $4.29 | $4.37 | $4.16 | $4.22 | 2.88M |
| Aug 18, 2026 | $4.24 | $4.35 | $4.20 | $4.23 | 3.43M |
| Aug 17, 2026 | $4.55 | $4.57 | $4.15 | $4.27 | 5.38M |
| Aug 14, 2026 | $4.49 | $4.635 | $4.45 | $4.60 | 3.66M |
| Aug 13, 2026 | $4.50 | $4.61 | $4.46 | $4.49 | 3.27M |
| Aug 12, 2026 | $4.37 | $4.54 | $4.36 | $4.54 | 4.76M |
| Aug 11, 2026 | $4.55 | $4.59 | $4.3401 | $4.39 | 4.33M |
| Aug 10, 2026 | $4.69 | $4.79 | $4.50 | $4.57 | 5.48M |
| Aug 7, 2026 | $4.72 | $4.92 | $4.62 | $4.76 | 7.67M |
| Aug 6, 2026 | $4.89 | $5.19 | $4.52 | $4.66 | 11.64M |
| Aug 5, 2026 | $4.26 | $4.31 | $4.12 | $4.14 | 4.61M |
| Aug 4, 2026 | $4.33 | $4.36 | $4.25 | $4.27 | 3.66M |
| Aug 3, 2026 | $4.23 | $4.375 | $4.17 | $4.33 | 3.93M |
| Jul 31, 2026 | $4.345 | $4.345 | $4.16 | $4.17 | 3.54M |
| Jul 30, 2026 | $4.23 | $4.36 | $4.19 | $4.34 | 2.52M |
The latest Smart Investors Daily articles mentioning CLOV.
CLOV research
Company profile and research snapshot.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 6, 2026 | UBS | Neutral | — |
| Jul 21, 2026 | Canaccord Genuity | Buy | — |
| Jun 11, 2026 | UBS | Neutral | — |
| Jun 4, 2026 | Canaccord Genuity | Buy | — |
| Mar 20, 2026 | Canaccord Genuity | Buy | — |
No generated briefing is available yet.
SeekingAlpha · Aug 19, 2026
Clover Health's current valuation ignores cash flow limits, MLR risk, CMS bonus uncertainty, and challenging software business. See why I rate CLOV stock a Sell.
SeekingAlpha · Aug 15, 2026
SeekingAlpha · Aug 14, 2026
Clover Health (CLOV) has delivered strong growth, profitability, and improved guidance, supporting my continued Strong Buy rating.
SeekingAlpha · Aug 13, 2026
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CLOV.
